Could another possible reason for the speedy settlement be that GSK are looking to licence LANI?It makes sense, a possible billion dollar deal for Biota/Sankyo that is currently being held back by the Relenza litigation?!?!?!?Any thoughts?
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint